Kimberly Manhard
Sr VP Reg Affairs & Operations, Ardea Biosciences, Inc./DE.
Companies
- Inhibrx Biosciences, Inc.Board member May 24, 2024 to now1
- Inhibrx, Inc.Board member Aug 18, 2020 to May 30, 20242
- HERON THERAPEUTICS, INC. /DE/Executive VP, Drug Development Jan 29, 2016 to Apr 17, 20233
- HERON THERAPEUTICS, INC. /DE/Board member Jan 15, 2014 to Jan 20, 20234
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Inhibrx Biosciences, Inc. INBX7,500 shares5$668.0K at $89.06Sep 15, 2026
- HERON THERAPEUTICS, INC. /DE/ HRTX28,330 shares6$9.9K at $0.35Apr 13, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 15, 2026Sold 500 shares at $105.05 of Inhibrx Biosciences, Inc.5
- Sep 14, 2026Sold 500 shares at $110.26 of Inhibrx Biosciences, Inc.5
- Sep 11, 2026Sold 500 shares at $111.78 of Inhibrx Biosciences, Inc.5
- Sep 9, 2026Sold 500 shares at $115.80 of Inhibrx Biosciences, Inc.7
- Sep 8, 2026Sold 500 shares at $115.14 of Inhibrx Biosciences, Inc.7
- Aug 28, 2024Bought 10,000 shares at $13.98 of Inhibrx Biosciences, Inc.8
- Apr 13, 2023Shares withheld for tax 1,417 shares at $2.88 of HERON THERAPEUTICS, INC. /DE/6
- Apr 13, 2023Exercised options 4,564 shares of HERON THERAPEUTICS, INC. /DE/6
- Apr 13, 2023Exercised options 1,250 shares of HERON THERAPEUTICS, INC. /DE/6
- Jan 13, 2023Shares withheld for tax 2,012 shares at $3.17 of HERON THERAPEUTICS, INC. /DE/9
- Jan 13, 2023Exercised options 4,564 shares of HERON THERAPEUTICS, INC. /DE/9
- Jan 13, 2023Exercised options 1,250 shares of HERON THERAPEUTICS, INC. /DE/9
- Oct 31, 2022Other 1,655 shares at $3.27 of HERON THERAPEUTICS, INC. /DE/9
- Oct 13, 2022Shares withheld for tax 2,012 shares at $3.76 of HERON THERAPEUTICS, INC. /DE/10
- Oct 13, 2022Exercised options 4,564 shares of HERON THERAPEUTICS, INC. /DE/10
- Oct 13, 2022Exercised options 1,250 shares of HERON THERAPEUTICS, INC. /DE/10
- Jul 13, 2022Shares withheld for tax 2,012 shares at $3.01 of HERON THERAPEUTICS, INC. /DE/11
- Jul 13, 2022Exercised options 4,564 shares of HERON THERAPEUTICS, INC. /DE/11
- Jul 13, 2022Exercised options 1,250 shares of HERON THERAPEUTICS, INC. /DE/11
- May 3, 2022Sold 1,504 shares at $4.76 of HERON THERAPEUTICS, INC. /DE/12
- Apr 29, 2022Other 1,504 shares at $3.84 of HERON THERAPEUTICS, INC. /DE/12
- Apr 13, 2022Shares withheld for tax 2,012 shares at $6.07 of HERON THERAPEUTICS, INC. /DE/13
- Apr 13, 2022Exercised options 4,564 shares of HERON THERAPEUTICS, INC. /DE/13
- Apr 13, 2022Exercised options 1,250 shares of HERON THERAPEUTICS, INC. /DE/13
- Jan 13, 2022Shares withheld for tax 2,012 shares at $8.30 of HERON THERAPEUTICS, INC. /DE/14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARInhibrx, Inc., Board member
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Sep 10, 2026
- 8SEC EDGARForm 4 filed Aug 30, 2024
- 9SEC EDGARForm 4 filed Jan 17, 2023
- 10SEC EDGARForm 4 filed Oct 17, 2022
- 11SEC EDGARForm 4 filed Jul 15, 2022
- 12SEC EDGARForm 4 filed May 4, 2022
- 13SEC EDGARForm 4 filed Apr 15, 2022
- 14SEC EDGARForm 4 filed Jan 14, 2022